Skip to main content

Table 1 Characteristics of patients

From: High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis

Patient Category Diagnosis RF Sex/age Duration of disease Therapy
1 Early RA RA - M/64 9 mo None
2 Early RA RA + M/63 3 mo NSAID
3 Early RA RA + F/77 1.5 mo None
4 Early RA RA ND M/20 6 mo NSAID
5 Early RA RA + M/40 11 mo None
6 Early RA RA + M/54 11 mo None
7 Early RA RA + F/62 10 mo NSAID
8 Early RA RA + M/75 18 mo NSAID
9 Early RA RA + M/82 12 mo NSAID
10 Early RA RA + M/51 11 mo NSAID
11 Early RA RA + F/76 12 mo Salazopyrin
12 Late RA RA - F/47 20 yr MTX
13 Late RA RA + F/67 40 yr MTX
14 Late RA RA + F/62 12 yr MTX, NSAID
15 Late RA RA + F/65 30 yr MTX, NSAID, Pred
16 Late RA RA + F/63 2 yr MTX, NSAID, Pred
17 Late RA RA + F/83 11 yr MTX, Pred
18 Late RA RA + M/38 22 yr Enbrel, MTX
19 Late RA RA + F/72 44 yr Cyclosporine, NSAID
20 Late RA RA + F/59 18 yr Salazopyrin, Glucosamine
21 Late RA RA + M/73 20 yr Paracetamol
22 Late RA RA + F/59 11 yr MTX, Remicade
23 Late RA RA + M/69 40 yr MTX, Pred, Cyclosporine
24 Late RA RA + M/53 7 yr Pred, NSAID
25 Late RA RA + F/55 4 yr Remicade
26 Late RA Juvenile RA + F/35 20 yr MTX, NSAID
27 Glu-study RA + M/53 7 yr Pred, NSAID
28 Glu-study RA + M/63 3 mo NSAID
29 Glu-study RA - F/35 20 yr MTX, NSAID
30 Glu-study Oligoarthritis - M/21 4 mo None
31 Glu-study Oligoarthritis - M/53 10 yr None
32 Glu-study Polyarthritis - F/43 12 yr Pred, NSAID
33 Glu-study Polyarthritis + F/73 2 yr MTX
34 Glu-study RA ND M/20 6 mo NSAID
35 Glu-study RA + F/55 4 yr Remicade
  1. Glu-study, before and after glucocorticoid study; F, female; M, male; mo, month; MTX, methotrexate; ND, not determined; NSAID, non-steroidal anti-inflammatory drugs; Pred, prednisolone; RA, rheumatoid arthritis; RF, rheumatoid factor; yr, year.